메뉴 건너뛰기




Volumn 176, Issue 8, 2002, Pages 381-386

Thiazolidinediones and type 2 diabetes: New drugs for an old disease

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ALANINE AMINOTRANSFERASE; ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; C PEPTIDE; CHOLESTEROL; FATTY ACID; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PLACEBO; ROSIGLITAZONE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SULFONYLUREA DERIVATIVE; TRIACYLGLYCEROL; TROGLITAZONE;

EID: 0037090599     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2002.tb04461.x     Document Type: Review
Times cited : (61)

References (45)
  • 1
    • 0008853463 scopus 로고    scopus 로고
    • AusDiab preliminary results media release
    • 30 May 2000
  • 3
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • (1998) Lancet , vol.352 , pp. 837-853
  • 5
    • 0024160877 scopus 로고
    • Role of insulin resistance in human disease
    • (1988) Diabetes , vol.37 , pp. 1595-1607
    • Reaven, G.M.1
  • 7
    • 0032983666 scopus 로고    scopus 로고
    • Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. Progressive requirement for multiple therapies (UKPDS 49)
    • (1999) JAMA , vol.281 , pp. 2005-2012
    • Turner, R.C.1    Cull, C.A.2    Frighi, V.3    Holman, R.R.4
  • 10
    • 0033857387 scopus 로고    scopus 로고
    • Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists
    • (2000) J Clin Invest , vol.106 , pp. 467-472
    • Olefsky, J.M.1
  • 11
    • 0031898610 scopus 로고    scopus 로고
    • PPARγ: Adipogenic regulator and thiazolidinedione receptor
    • (1998) Diabetes , vol.47 , pp. 507-514
    • Spiegelman, B.M.1
  • 25
    • 0034933056 scopus 로고    scopus 로고
    • Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: A randomized, placebo-controlled study
    • (2001) Am J Med , vol.111 , pp. 10-17
    • Kipnes, M.S.1    Krosnick, A.2    Rendell, M.S.3
  • 26
    • 0034531195 scopus 로고    scopus 로고
    • Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: A randomized, placebo-controlled study
    • (2000) Clin Ther , vol.22 , pp. 1395-1409
    • Einhorn, D.1    Rendell, M.2    Rosenzweig, J.3
  • 30
    • 0342471759 scopus 로고    scopus 로고
    • A comparison in a clinical setting of the efficacy and side-effects of three thiazolidinediones
    • [letter]
    • (2000) Diabetes Care , vol.23 , pp. 557
    • King, A.B.1
  • 33
    • 0000875145 scopus 로고    scopus 로고
    • Rosiglitazone is superior to glyburide in reducing fasting plasma glucose after one year of treatment in type 2 diabetic patients
    • [abstract]
    • (1999) Diabetes , vol.48 , Issue.SUPPL. 1
    • Charbonnel, B.1    Lonnqvist, F.2    Jones, N.P.3
  • 34
    • 0035832506 scopus 로고    scopus 로고
    • Lessons form the glitazones: A story of drug development
    • (2001) Lancet , vol.357 , pp. 1870-1875
    • Gale, E.A.M.1
  • 40
    • 0035928644 scopus 로고    scopus 로고
    • Hepatocellular injury in a patient receiving pioglitazone
    • [letter]
    • (2001) Ann Intern Med , vol.135 , pp. 306
    • Maeda, K.1
  • 44
    • 85031517545 scopus 로고    scopus 로고
    • Technology appraisal guidance 9: Guidance on rosiglitazone for type 2 diabetes
  • 45
    • 0008822174 scopus 로고    scopus 로고
    • Technology appraisal guidance 21: Guidance on pioglitazone for type 2 diabetes


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.